Dai Ogata

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab et al. · Cancer Cell · 2022 · 314 citations · Full text

Immune Evasion, Tumor Immunology, Cancer Immunosurveillance +5

Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients

Kaori Sakaizawa, Atsuko Ashida, Aya Uchiyama et al. · Journal of Dermatological Science · 2015 · 118 citations

Japanese Melanoma Patients, Medicine, Photocarcinogenesis +10

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa et al. · Cancer Medicine · 2019 · 106 citations · Full text

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma

Sun-Hee Kim, Jason Roszik, Sung-Nam Cho et al. · Clinical Cancer Research · 2018 · 53 citations · Full text

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

Yasuhiro Nakamura, Kenjiro Namikawa, Shusuke Yoshikawa et al. · ESMO Open · 2021 · 50 citations · Full text